Von Willebrand disease secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Von Willebrand disease}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ==Referen..." |
Prince Djan (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Von Willebrand disease}} | {{Von Willebrand disease}} | ||
{{CMG}} {{PTD}} | |||
==Overview== | |||
==Prevention== | |||
*There are no known preventive measures for von Willebrand disease. | |||
*In families with type 3 disease, genetic analysis may be useful for counseling.<ref name="pmid26245874">{{cite journal |vauthors=Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Toll T, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto Mdel M, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Borràs N, Vidal F |title=Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm |journal=Thromb. Haemost. |volume=115 |issue=1 |pages=40–50 |year=2016 |pmid=26245874 |doi=10.1160/TH15-04-0282 |url=}}</ref> | |||
==References== | ==References== | ||
Revision as of 21:32, 15 December 2016
|
Von Willebrand disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Von Willebrand disease secondary prevention On the Web |
|
American Roentgen Ray Society Images of Von Willebrand disease secondary prevention |
|
Risk calculators and risk factors for Von Willebrand disease secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Prince Tano Djan, BSc, MBChB [2]
Overview
Prevention
- There are no known preventive measures for von Willebrand disease.
- In families with type 3 disease, genetic analysis may be useful for counseling.[1]
References
- ↑ Batlle J, Pérez-Rodríguez A, Corrales I, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jiménez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Toll T, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto Mdel M, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Borràs N, Vidal F (2016). "Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm". Thromb. Haemost. 115 (1): 40–50. doi:10.1160/TH15-04-0282. PMID 26245874.